HUMA THERAPEUTICS LIMITED (07725451) is a private limited company registered in LONDON, incorporated in 2011. The company operates in the other telecommunications activities sector. We currently track 18 data signals for this company from 13 sources. Risk assessment: 91/100 ("robust"), reflecting a strong compliance and financial profile.
HUMA THERAPEUTICS LIMITED is an active private limited company incorporated in 2011 in London, operating in other telecommunications activities with three active officers and no active charges.
Limited public data available — fewer records than most UK companies. Risk score of 91 indicates a strong compliance profile.
HUMA THERAPEUTICS LIMITED is 1 of 1,921 other telecommunications activities companies in LONDON, out of 8,983 active companies in this sector nationally (10,564 including dissolved).
The 2 directors of HUMA THERAPEUTICS LIMITED are connected to 8 other companies.
None of these connected companies have been dissolved.
HUMA THERAPEUTICS LIMITED is listed as the proprietor of 1 property in the HM Land Registry.
Properties are located in Greater London.
HUMA THERAPEUTICS LIMITED has been awarded 2 government contracts with a combined value of £339K.
The most recent contract was with Kettering General Hospital NHS Foundation Trust (11 Mar 2025).
| Year | Turnover | Profit | Net Assets |
|---|---|---|---|
| 31 Dec 2024 | — | -£28.8M | — |
| 31 Dec 2022 | — | £2K | — |
| 31 Dec 2021 | — | -£25.8M | — |
HUMA THERAPEUTICS LIMITED has received 1 Innovate UK grant.
This company profile is built from 11 official data sources: Ch Officers, Companies House, Contracts Finder, GLEIF, Gateway to Research, HM Land Registry, HMRC Trade Info, ICO, Innovate UK, SBTi, WHOIS.
HUMA THERAPEUTICS LIMITED is an active private limited company incorporated in 2011 in London, operating in other telecommunications activities with three active officers and no active charges..
Current directors include DR RICH KHATIB, MR DANOOSH VAHDAT, MR ESKANDAR MALEKI.
HUMA THERAPEUTICS LIMITED is registered in LONDON, United Kingdom.
HUMA THERAPEUTICS LIMITED operates under SIC code 61900 — Other telecommunications activities.
HUMA THERAPEUTICS LIMITED has a risk score of 91 out of 100, classified as "Robust". This score is calculated from 18 data signals across 13 government sources.
The next accounts for HUMA THERAPEUTICS LIMITED are due on 29 Sept 2026.
Yes, HUMA THERAPEUTICS LIMITED was previously known as HUMAFORHEALTH LIMITED, MEDOPAD LTD.
Yes, HUMA THERAPEUTICS LIMITED is listed as the proprietor of 1 property in the HM Land Registry, located in Greater London.
Yes, HUMA THERAPEUTICS LIMITED has been awarded 2 government contracts with a combined value of £339K.
According to the latest filed accounts (31 Dec 2024), HUMA THERAPEUTICS LIMITED has 1 employee.
The dissolution rate for the other telecommunications activities sector in the UK is 0.3%. The average company age in this sector is 10.6 years.
HUMA THERAPEUTICS LIMITED is currently listed as "Active" on Companies House, indicating it is still a registered company. An "Active" status means the company has not been dissolved, struck off, or entered into liquidation.
HUMA THERAPEUTICS LIMITED is registered as a Private Limited Company, which is a company limited by shares whose shares are not offered to the general public. It is the most common type of UK company, offering limited liability to its shareholders.
HUMA THERAPEUTICS LIMITED was incorporated on 2 Aug 2011, making it 15 years old. The company remains active and in good standing.
HUMA THERAPEUTICS LIMITED is classified under SIC code 61900 (Other telecommunications activities). The Standard Industrial Classification system is used by the UK government to categorise businesses by their primary economic activity.
We track 18 data signals from 13 official government sources for HUMA THERAPEUTICS LIMITED.